Ambu — M&A Activity 2016

Sep 28, 2016

Ambu
Ideas that work for life

Ambu finalises acquisition of ETView Medical Ltd.

Acquisition strengthens Ambu’s visualisation portfolio.

On 22 June 2016, Ambu announced that the company had signed a conditional agreement to acquire Israeli-based ETView Medical Ltd.

The completion of the agreement has awaited the final approval of ETView’s shareholders, which is now in place. In addition, the remaining regulatory conditions for the agreement have been met, and Ambu’s acquisition of ETView is therefore final.

Increased relevance for doctors and patients

Ambu’s President and CEO, Lars Marcher, says: “The relatively small but focused organisation of ETView has developed an excellent product line of single-use airway tubes, and I truly believe that Ambu is the right company to take this product to the next level. Ambu has the necessary global presence to support the existing sales as well as introduce new hospitals in North America, Europe and the Asia-Pacific to ETView’s technology. Ambu’s portfolio of single-use visualisation products is now even stronger and more relevant to doctors and patients.”

The acquisition price is USD 16m on a debt and cash free basis, which will be financed out of Ambu’s existing credit lines. ETView is expected to be de-listed from the Tel Aviv stock exchange as of 5 October 2016, after which the integration between Ambu and ETView will be set in motion.

Contact

Lars Marcher, President & CEO, tel. +45 5136 2490, e-mail: lm@ambu.com

Ambu A/S
Baltorpbakken 13
2750 Ballerup
Denmark
Tel. +45 7225 2000
CVR-nr.: 63 64 49 19
www.ambu.com

About Ambu

Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our newest landmark solutions like the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,350 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.

Ambu
Company announcement no. 43 2015/16
28 September 2016